Skip to Content

MYLAN 143 MYLAN 143 (Indomethacin 25 mg)

Pill with imprint MYLAN 143 MYLAN 143 is Green, Capsule-shape and has been identified as Indomethacin 25 mg. It is supplied by Mylan Pharmaceuticals Inc..

Indomethacin is used in the treatment of back pain; bursitis; ankylosing spondylitis; bartter syndrome; cluster headaches and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 143 MYLAN 143

Indomethacin 25 mg MYLAN 143 MYLAN 143
Indomethacin 25 mg MYLAN 143 MYLAN 143 Front
Indomethacin 25 mg MYLAN 143 MYLAN 143 Back
Indomethacin 25 mg MYLAN 143 MYLAN 143

Indomethacin

Imprint
MYLAN 143 MYLAN 143
Strength
25 mg
Color
Green
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, gelatin, FD&C Green No. 3, magnesium stearate, microcrystalline cellulose, cellulose powdered, sodium lauryl sulfate, sodium starch glycolate type A potato, titanium dioxide, D&C Yellow No. 10, ferrosoferric oxide, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-0143 Mylan Pharmaceuticals Inc.
51079-0190 UDL Laboratories Inc.
54569-0277 A-S Medication Solutions, LLC (repackager)
66267-0119 Nucare Pharmaceuticals Inc. (repackager)
54569-4123 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Related Images for "MYLAN 143 MYLAN 143"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.